Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Tissue Repair Ltd ( (AU:TRP) ) has provided an update.
Tissue Repair Limited has announced its Annual General Meeting, scheduled for November 24, 2025, in Sydney. The meeting will allow shareholders to vote on significant company decisions, emphasizing the importance of shareholder participation in shaping the company’s future. The company is providing electronic access to the meeting notice and proxy voting options to facilitate shareholder engagement.
More about Tissue Repair Ltd
Tissue Repair Limited (ASX: TRP) is a Phase 3 biotechnology company focused on developing advanced wound healing agents. The company is progressing its lead drug candidate TR987® for chronic wounds and commercializing TR Pro+®, a topical treatment designed to enhance healing and improve skin quality post-cosmetic or medical procedures. Their proprietary Glucoprime® API supports a growing pipeline of therapeutic solutions.
Average Trading Volume: 107,137
Technical Sentiment Signal: Buy
For detailed information about TRP stock, go to TipRanks’ Stock Analysis page.